Analysis pipeline for the detection of mutations causative of rare diseases on whole exome sequencing data
Antonio Rueda(Instituto de Investigación Biomédica de Málaga), Javier Santoyo‐López, José Carbonell‐Caballero(Centre for Genomic Regulation), Joaquı́n Dopazo(Fundación Progreso y Salud), Luis Miguel González Cruz, Francisco J. López, Enrique Vidal(Leitat Technological Center), Pablo Arce, Guillermo Antiñolo(Centre for Biomedical Network Research on Rare Diseases), Jorge Jiménez(Centre for Biomedical Network Research on Rare Diseases)
Cited by 0
Related Papers
Differential expression in RNA-seq: A matter of depth
|Genome Research|2011|1.7k
A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium
|Nature Biotechnology|2014|1.1k
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
|The Lancet Oncology|2021|618
Transcription factors orchestrate dynamic interplay between genome topology and gene regulation during cell reprogramming
|Nature Genetics|2018|385
The effects of death and post-mortem cold ischemia on human tissue transcriptomes
|Nature Communications|2018|338